MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Myoclonus: Etiology and Pathogenesis"

  • 2019 International Congress

    Regardless of impaired renal function, negative myoclonus can be induced by gabapetin and pregabalin

    DY. Kwon, MH. Park (Gyenggi-Do, Republic of Korea)

    Objective: This study evaluated pregabalin- or gabapentin-induced negative myoclonus according to renal function. Background: Gabapentin and pregabalin are commonly used to control neuropathic pain and epilepsy.…
  • 2019 International Congress

    Drug-induced Negative Myoclonus: A Case Report

    L. Lerjefors, M. Mainardi, A. Antonini, M. Carecchio (Padova, Italy)

    Objective: To report on a case of drug-induced negative myoclonus in a patient with a complex oral therapy. Background: Myoclonus is a shock-like jerk due…
  • 2019 International Congress

    Adult-Onset Parainfectious Opsoclonus-Myoclonus: Report of Two Cases

    MI. Gaston, I. Rubio, J. Muruzabal, R. Larumbe, M. Martin, L. Martinez (Pamplona, Spain)

    Objective: Present two cases of Adult-Onset parainfectious Opsoclonus-Myoclonus Syndrome with fast and good recovery Background: Adult-Onset Opsoclonus-Myoclonus  (AOMS) is a rare disorder. Two main causes…
  • 2019 International Congress

    Steroid-responsive myoclonus in the context of pembrolizumab treatment: a novel neurological phenotype.

    M. Murphy, S. O'Dowd, M. Alexander (Dublin, Ireland)

    Objective: To outline a novel immunologically-mediated neurological adverse event associated with the use of a medication class which has an expanding range of applications [1].…
  • 2019 International Congress

    High dose amantadine therapy may cause increased falling in Parkinson’s patients

    L. Verhagen Metman (Chicago, IL, USA)

    Objective: To report a possible association between high dose amantadine and increased falling in patients with Parkinson’s disease (PD). Background: Amantadine is used in PD…
  • 2018 International Congress

    Tardive Myoclonus: A Case Report

    S. Gazioglu, F. Civil Arslan, V. Altunayoglu Cakmak, M. Korucuk, M. Ozmenoglu (Trabzon, Turkey)

    Objective: To report a patient with late-onset myoclonus after treatment with antipsychotic drugs which is a rare variant of tardive movement disorders. Background: The use…
  • 2018 International Congress

    Myoclonus in the pediatric age group: A retrospective analysis of clinical and electrophysiological characteristics of patients referred to an electrophysiology laboratory

    A. Gunduz, H. Yılmaz, V. Demirbilek, C. Yalçınkaya, N. Yeni, S. Saltık, M. E. Kızıltan (Istanbul, Turkey)

    Objective: We aimed to investigate clinical and electrophysiological features myoclonus in the pediatric age group. Background: Myoclonus is a movement disorder characterized by sudden, brief…
  • 2018 International Congress

    Movement Disorders Phenomenology in Focal Motor Seizures

    A. Fasano, C. Di Bonaventura, F. Bove, A. Espay, F. Morgante, G. Fabbrini, R. Munhoz, D. Andrade, F. Borlot, F. Bui, G. Di Gennaro, R. Iorio, H. Katzberg, M. Luigetti, P. Striano, G. Defazio, A. Berardelli (Toronto, ON, Canada)

    Objective: To examine the extent to which focal motor seizures can present with a phenomenology fulfilling diagnostic criteria for one or more movement disorder. Background:…
  • 2017 International Congress

    Orthostatic myoclonus after brain tumor surgery and radiation

    J. Cutsforth-Gregory, J. Hammack, J. Matsumoto (Rochester, MN, USA)

    Objective: To review the clinical and electrophysiological characteristics of orthostatic myoclonus (OM) in the setting of brain tumor treatment, a novel association. Background: OM is…
  • 2017 International Congress

    Reappraisal of Progressive Myoclonus Ataxia

    S. vd Veen, R. Zutt, T. De Koning, M. Tijssen (Groningen, Netherlands)

    Objective: To define the clinical, electrophysiological and etiological features of progressive myoclonus ataxia (PMA). Background: PMA, formerly known as the Ramsay Hunt syndrome, is a…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley